Abeona Therapeutics (ABEO) - Net earnings per share (EPS TTM)

Symbol and logo of brand Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics (ABEO) controls the niche of cell therapy for skin pathologies by integrating the EB-101 drug into surgery. Net income per share over the last 12 months on this chart on GURU.Markets reflects a trend where -1.12 becomes the new value of the indicator. This is driven by the expansion of Pz-cel in the orphan market and the absence of geopolitical risks due to the localization of production in the US.

ABEO (abeonatherapeutics.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Abeona (ABEO)

- share price and expert price forecast:
General company analysis:Abeona Therapeutics Inc. (ABEO)
Mass-produced product of Abeona Therapeutics, Inc.

Abeona Therapeutics (ABEO) ensures the stable production of orphan drugs through its own high-tech facility in Ohio featuring autonomous cleanrooms. The business's annual equity income, reflected via the rolling 12-month net income per share, allows for a real-time assessment of this infrastructure's efficiency, where an upward trend confirms asset capitalization, while a downward reversal signals risks of company overvaluation.

Competitors of Abeona Therapeutics (ABEO)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)